Validation, Commissioning & Design Featured Articles
-
How Can Data Translation Challenges In CRO Partnerships Be Overcome?
1/29/2026
Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.
-
Precision Medicine In IMIDs - The Path To Improved Healthcare Outcomes
1/29/2026
Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.
-
Enhancing Biopharma ROI With In-House Long-Read Sequencing
1/29/2026
Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.
-
Accelerating Batch Release With Agentic AI
1/29/2026
Agentic AI is redefining manufacturing by accelerating batch release and sharpening real‑time insights. With the right data and governance, teams can gain faster analytics and improved efficiency.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return
1/29/2026
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Enabling NGS-Based Product Characterization And Biosafety Assays
1/29/2026
Evolving regulations are shaping the adoption of NGS for biosafety and product characterization. Learn what teams must consider when validating modern sequencing assays within GMP‑regulated environments.
-
Modified Release Tablets: Strategies For Optimising Drug Delivery
1/29/2026
Modified‑release tablets control drug release to improve treatment effectiveness, reduce side effects, and enhance patient adherence.
-
How To Achieve Right-First-Time Manufacturing
1/21/2026
Modernizing QC requires more than isolated fixes. Discover how cloud-based platforms unify systems, automate workflows, and improve data access to help labs reduce cycle times and minimize rework.
-
What To Expect From A Sterile Injectables CDMO
1/20/2026
Sterile injectable manufacturing demands built‑in contamination control, rigorous monitoring, skilled personnel, and robust quality systems, far beyond sterility testing, to ensure safety, compliance, and reliable CDMO performance.
-
Why Risk-Based Thinking Is Transforming Life Sciences Validation
1/16/2026
The FDA’s CSA framework replaces traditional CSV with a risk-based approach, reducing inefficiencies and enabling faster innovation. Learn why this shift matters for your organization.